Mirtazapine

What is Mirtazapine?

Mirtazapine is an atypical antidepressant medication that belongs to a class called noradrenergic and specific serotonergic antidepressants (NaSSAs). It is primarily prescribed to treat major depressive disorder and is known for its unique mechanism of action that differs from more commonly used antidepressants like SSRIs. Mirtazapine is also sometimes used off-label for anxiety disorders and sleep disturbances due to its sedating properties.

Uses

Mirtazapine has several documented clinical applications:

• Major Depressive Disorder: The primary FDA-approved use for treating moderate to severe depression, particularly effective in patients with sleep and appetite disturbances
• Anxiety Disorders: Often prescribed off-label for generalized anxiety disorder and post-traumatic stress disorder, especially when combined with depression
• Insomnia: Sometimes used off-label at lower doses to help with sleep disorders due to its strong sedating effects
• Appetite Stimulation: May be prescribed off-label for patients with significant weight loss or eating difficulties, as it commonly increases appetite
• Nausea and Vomiting: Occasionally used off-label to manage severe nausea, particularly in cancer patients or those with chronic conditions

How it works

Mirtazapine works by blocking specific receptors in the brain, including alpha-2 adrenergic receptors, which increases the release of both norepinephrine and serotonin neurotransmitters. Unlike SSRIs that block serotonin reuptake, mirtazapine enhances serotonin and norepinephrine activity through receptor antagonism. It also blocks histamine H1 receptors, which contributes to its sedating effects and appetite stimulation.

Side effects

Common side effects include:

Submit Your Paper

• Drowsiness and sedation
• Increased appetite and weight gain
• Dry mouth
• Constipation
• Dizziness
• Fatigue
• Increased cholesterol levels
• Confusion or difficulty concentrating

Serious side effects to watch for:

• Severe allergic reactions including skin rash or swelling
• Suicidal thoughts or behavior, especially in young adults
• Agranulocytosis (dangerously low white blood cell count)
• Serotonin syndrome when combined with other serotonergic medications
• Severe liver problems

Warnings and precautions

• Suicide Risk: Increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults under 25, requiring close monitoring especially during the first few months of treatment
• Pregnancy and Breastfeeding: Classified as pregnancy category C; should only be used when benefits outweigh risks, and passes into breast milk
• Liver and Kidney Disease: Requires dose adjustment in patients with hepatic or renal impairment, as the drug is metabolized by the liver
• Blood Disorders: Patients should be monitored for signs of infection due to potential white blood cell count reduction
• Cardiovascular Conditions: Use with caution in patients with heart disease, as it may affect heart rhythm and blood pressure

Interactions

• MAO Inhibitors: Potentially fatal interaction causing serotonin syndrome; must wait at least 14 days between stopping MAOIs and starting mirtazapine
• CNS Depressants: Alcohol, benzodiazepines, and opioids can increase sedation and respiratory depression risk
• Blood Thinners: Warfarin and other anticoagulants may have altered effects due to protein binding displacement
• Tramadol: Increases risk of serotonin syndrome when combined with this pain medication
• St. John’s Wort: This herbal supplement can reduce mirtazapine effectiveness and increase serotonin syndrome risk
• Phenytoin: This seizure medication can increase mirtazapine metabolism, reducing its effectiveness
• Cimetidine: This stomach acid reducer can increase mirtazapine blood levels
• SSRIs/SNRIs: Other antidepressants can increase serotonin syndrome risk when used concurrently

Check interactions with the GMJ Interaction Checker

Dosage

For adults with major depressive disorder, the typical starting dose is 15 mg taken once daily, usually at bedtime due to its sedating effects. The dose may be gradually increased by healthcare providers to 30 mg or 45 mg daily based on response and tolerability. Maximum recommended dose is typically 45 mg per day. For elderly patients or those with kidney or liver problems, lower starting doses may be recommended. Dosage should always be determined and adjusted by a healthcare provider, and the medication should not be stopped abruptly as withdrawal symptoms may occur.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).